Role of heme oxygenase-1 in vascular disease

Current Pharmaceutical Design

Volumn 14, Issue 5, 2008, Pages 422-428

  Chung, Hun Taeg ^a   Pae, Hyun Ock ^a   Cha, Young Nam ^b  

^a Wonkwang University   (South Korea)

^b Inha University School of Medicine   (South Korea)

Author keywords

Carbon monoxide; Heme oxygense 1; Hydrogen sulfide; Nitric oxide; Vascular disease

Indexed keywords

ACTIVATING TRANSCRIPTION FACTOR 6; BILIRUBIN; BILIVERDIN; BUTYLATED HYDROXYANISOLE; CARBON MONOXIDE; CURCUMIN; CYSTATHIONINE BETA SYNTHASE; CYSTATHIONINE GAMMA LYASE; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; FERRITIN; HEME OXYGENASE 1; HYDROGEN SULFIDE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 6; MITOGEN ACTIVATED PROTEIN KINASE; NITRIC OXIDE; PACLITAXEL; PADGEM PROTEIN; PHOSPHATIDYLINOSITOL 3 KINASE; PROBUCOL; PROTEIN KINASE C; SYNAPTOPHYSIN; TRANSCRIPTION FACTOR AP 1; TRANSCRIPTION FACTOR NRF2; TUMOR NECROSIS FACTOR ALPHA;

ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; ANTIOXIDANT RESPONSIVE ELEMENT; APOPTOSIS; ATHEROSCLEROSIS; CELL DEATH; CELL PROLIFERATION; CELL PROTECTION; CELL SURVIVAL; ENDOPLASMIC RETICULUM; ENDOTHELIUM CELL; ENZYME ACTIVITY; ENZYME INDUCTION; ENZYME INHIBITION; GENE EXPRESSION REGULATION; HUMAN; ISCHEMIA; LUNG ISCHEMIA; NONHUMAN; OXIDATION REDUCTION STATE; OXIDATIVE STRESS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; REVIEW; SIGNAL TRANSDUCTION; SMOOTH MUSCLE FIBER; VASCULAR DISEASE; VASCULAR SMOOTH MUSCLE CELL; VASODILATATION;

ANIMALS; ATHEROSCLEROSIS; CARBON MONOXIDE; ENDOTHELIUM, VASCULAR; ENZYME INDUCTION; HEME OXYGENASE-1; HUMANS; HYDROGEN SULFIDE; NITRIC OXIDE; VASCULAR DISEASES;

EID: 42049091051     PISSN: 13816128     EISSN: None     Source Type: Journal    
DOI: 10.2174/138161208783597335     Document Type: Review

References (93)

1. Adams B, Xiao Q, Xu Q. Stem cell therapy for vascular disease. Trends Cardiovasc Med 2007; 17: 246-51.
2. Frisinghelli A, Mafrici A. Regression or reduction in progression of atherosclerosis, and avoidance of coronary events, with lovastatin in patients with or at high risk of cardiovascular disease: A review. Clin Drug Investig 2007; 27: 591-604.
3. Wang LJ, Lee TS, Lee FY, Pai RC, Chau LY. Expression of heme oxygenase-1 in atherosclerotic lesions. Am J Pathol 1998; 152: 711-20.
4. Ishikawa K, Navab M, Leitinger N, Fogelman AM, Lusis AJ. Induction of heme oxygenase-1 inhibits the monocyte transmigration induced by mildly oxidized LDL. J Clin Invest 1997; 100: 1209-16.
5. Meilhac O, Zhou M, Santanam N, Parthasarathy S. Lipid peroxides induce expression of catalase in cultured vascular cells. J Lipid Res 2000; 41: 1205-13.
6. Kawashima A, Oda Y, Yachic A, Koizumi S, Nakanishi I. Heme oxygenase-1 deficiency: The first autopsy case. Hum Pathol 2002; 33; 125-30.
7. Yachie A, Niida Y, Wada T, Igarashi N, Kaneda H, Toma T, et al. Oxidative stress causes enhanced endothelial cell injury in human heme oxygenase-1 deficiency. J Clin Invest 1999; 103: 129-35.
8. Wiesel P, Patel AP, DiFonzo N, Marria PB, Sim CU, Pellacani A, et al. Endotoxin-induced mortality is related to increased oxidative stress and end-organ dysfunction, not refractory hypotension, in heme oxygenase-1-deficient mice. Circulation 2000; 102: 3015-22.
9. Miyoshi T, Tian J, Matsumoto AH, Shi W. Differential response of vascular smooth muscle cells to oxidized LDL in mouse strains with different atherosclerosis susceptibility. Atherosclerosis 2006; 189: 99-105.
10. Anwar AA, Li FY, Leake DS, Ishii T, Mann GE, Siow RC. Induction of heme oxygenase 1 by moderately oxidized low-density lipoproteins in human vascular smooth muscle cells: Role of mitogen-activated protein kinases and Nrf2. Free Radic Biol Med 2005; 39: 227-36.
11. Alam J, Cook JL. Transcriptional regulation of the heme oxygenase-1 gene via the stress response element pathway. Curr Pharm Des 2003; 9: 2499-511.
12. Chen XL, Kunsch C. Induction of cytoprotective genes through Nrf2/ antioxidant response element pathway: A new therapeutic approach for the treatment of inflammatory diseases. Curr Pharm Des 2004; 10: 879-91
13. Ryter SW, Morse D, Choi AM. Carbon monoxide and bilirubin: Potential therapies for pulmonary/vascular injury and disease. Am J Respir Cell Mol Biol 2007; 36: 175-82.
14. Ryter SW, Alam J, Choi AM. Heme oxygenase-1/carbon monoxide: From basic science to therapeutic applications. Physiol Rev 2006; 86: 583-650.
15. 2S) - the third gas of interest for pharmacologists. Pharmacol Rep 2007; 59: 4-24.
16. Zuckerbraun BS, Billiar TR, Otterbein SL, Kim PK, Liu F, Choi AM, et al. Carbon monoxide proLects against liver failure through nitric oxide-induced heme oxygenase 1. J Exp Med 2003; 198: 1707-16.
17. Oh GS, Pae HO, Choi BM, Chae SC, Lee HS, Ryu DG, et al. 3-Hydroxyanthranilic acid, one of metabolites of tryptophan via indoleamine 2,3-dioxygenase pathway, suppresses inducible nitric oxide synthase expression by enhancing heme oxygenase-1 expression. Biochem Biophys Res Commun 2004; 320: 1156-62.
18. Choi BM, Pac HO, Kim YM, Chung HT. Nitric oxide-mediated cytoprotection of hepatocytes from glucose deprivation-induced cytotoxicity: involvement of heme oxygenase-1. Hepatology 2003; 37: 810-23.
19. Kirkby KA, Adin CA. Products of heme oxygenase and their potential therapeutic applications. Am J Physiol Renal Physiol 2006; 290: F563-71.
20. Balla J, Vercellotti GM, Jeney V, Yachie A, Varga Z, Eaton JW, et al. Heme, heme oxygenase and ferritin in vascular endothelial cell injury. Mol Nutr Food Res 2005; 49: 1030-43.
21. Morita T. Heme oxygenase and atherosclerosis. Arterioscler Thromb Vasc Biol 2005; 25: 1786-95.
22. Srisook K, Kim C. Cha YN. Molecular mechanisms involved in enhancing HO-1 expression: De-repression by heme and activation by Nrf2, the "one-two" punch. Antioxid Redox Signal 2005; 7: 1674-87.
23. Farombi EO, Surh YJ. Heme oxygenase-1 as a potential therapeutic target for hepatoprotection. J Biochem Mol Biol 2006; 39: 479-91.
24. Lim HJ, Lee KS, Lee S, Park JH, Choi HE, Go SH, et al. 15d-PGJ2 stimulates HO-1 expression through p38 MAP kinase and Nrf-2 pathway in rat vascular smooth muscle cells. Toxicol Appl Pharmacol 2007; 223: 20-7.
25. Cheng PY, Lee YM, Shih NL, Chen YC, Yen MH. Heme oxygenase-1 contributes to the cytoprotection of alpha-lipoic acid via activation of p44/42 mitogen-activated protein kinase in vascular smooth muscle cells. Free Radic Biol Med 2006; 40: 1313-22.
26. Ogborne RM, Rushworth SA, O'Connell MA. Alpha-lipoic acid-induced heme oxygenase-1 expression is mediated by nuclear factor erythroid 2-related factor 2 and p38 mitogen-activated protein kinase in human monocytic cells. Arterioscler Thromb Vasc Biol 2005; 25: 2100-5.
27. Choi BM, Kim YM, Jeong YR, Pae HO, Song CE, Park JE, et al. Induction of herne oxygenase-1 is involved in anti-proliferative effects of paclitaxel on rat vascular smooth muscle cells. Biochem Biophys Res Commun 2004; 321: 132-7.
28. Khor TO, Huang MT, Kwon KH, Chan JY, Reddy BS, Kong AN. Nrf2-deficient mice have an increased susceptibility to dextran sulfate sodium-induced colitis. Cancer Res 2006; 66: 11580-4.
29. Levonen AL, Inkala M, Heikura T, Jauhiainen S, Jyrkkanen HK, Kansanen E, et al. Nrf2 gene transfer induces antioxidant enzymes and suppresses smooth muscle cell growth in vitro and reduces oxidative stress in rabbit aorta in vivo. Arterioseler Thromb Vasc Biol 2007; 27: 741-7.
30. Poss KD, Tonegawa S. Reduced stress defense in heme oxygenase 1-deficient cells. Proc Natl Acad Sci USA 1997; 94: 10925-30.
31. Stocker R, Glazer AN, Ames BN. Antioxidant activity of albumin-bound bilirubin. Proc Natl Acad Sci USA 1987; 84: 5918-22.
32. Datla SR, Dusting GJ, Mori TA, Taylor CJ, Croft KD, Jiang F. Induction of heme oxygenase-1 in vivo suppresses NADPH oxidase derived oxidative stress. Hypertension 2007; 50: 636-42.
33. Matsumoto H, Ishikawa K, Itabe H, Maruyama Y. Carbon monoxide and bilirubin from heme oxygenase-1 suppresses reactive oxygen species generation and plasminogen activator inhibitor-1 induction. Mol Cell Biochem 2006; 291: 21-8.
34. Kapturczak MH, Wasserfall C, Brusko T, Campbell-Thompson M, Ellis TM, Atkinson MA, et al. Heme oxygenase-1 modulates early inflammatory responses: Evidence from the heme oxygenase-1-deficient mouse. Am J Pathol 2004; 165: 1045-53.
35. Pae HO, Oh GS, Choi Bm, Chae SC, Kim YM, Chung KK, et al. Carbon monoxide produced by heme oxygenase-1 suppresses T cell proliferation via inhibition of IL-2 production. J Immunol 2004; 172: 4744-51.
36. Nakao A, Moore BA, Murase N, Liu F, Zuckerbraun BS, Bach FH, et al. Immunomodulatory effects of inhaled carbon monoxide on rat syngeneic small bowel graft motility. Gut 2003; 52: 1278-85.
37. Soares MP, Seldon MP, Gregoire IP, Vassilevskaia T, Berberat PO, Yu J, et al. Heme oxygenase-1 modulates the expression of adhesion molecules associated with endothelial cell activation, J Immunol 2004; 172: 3553-63.
38. Duckers HJ, Boehm M, True AL, Yet SF, San H, Park JL, et al. Heme oxygenase-1 protects against vascular constriction and proliferation. Nat Med 2001; 7: 693-8.
39. Chen S, Sega M, Agarval A. "Lumen digestion" technique for isolation of aortic endothelial cells from heme oxygenase-1 knockout mice. Biotechniques 2004; 37: 84-6, 88-9.
40. Durante W. Heme oxygenase-1 in growth control and its clinical application to vascular disease. J Cell Physiol 2003; 195: 373-82.
41. Brouard S, Otterbein LE, Anrather J, Tobiasch E, Bach FH, Choi AM, et al. Carbon monoxide generated by heme oxygenase 1 suppresses endothelial cell apoptosis. J Exp Med 2000; 192: 1015-26.
42. Liu XM, Chapman GB, Wang H, Durante W. Adenovirus-mediated heme oxygenase-1 gene expression stimulates apoptosis in vascular smooth muscle cells. Circulation 2002; 105: 79-84.
43. Petrache I, Otterbein LE, Alam J, Wiegand GW, Choi AM. Heme oxygenase-1 inhibits TNF-alpha-induced apoptosis in cultured fibroblasts. Am J Physiol Lung Cell Mol Physiol 2000; 278: L312-9.
44. Wang R, Shamloul R, Wang X, Meng Q, Wu L, Sustained normalization of high blood pressure in spontaneously hypertensive rats by implanted hemin pump. Hypertension 2006; 48: 685-92.
45. Wang R. Two's company, three's a crowd: Can H2S be the third endogenous gaseous transmitter? FASEB J 2002; 16: 1792-8.
46. Moncada S, Palmer RM, Higgs EA. Nitric oxide: Physiology, pathophysiology, and pharmacology. Pharmacol Rev 1991; 43: 109-42.
47. Zhao W, Zhang J, Lu Y, Wang R. The vasorelaxant effect of H(2)S as a novel endogenous gaseous K(ATP) channel opener. EMBO J 2001; 20: 6008-16.
48. Abe K, Kimura H. The possible role of hydrogen sulfide as an endogenous neuromodulator. J Neurosci 1996; 16: 1066-71.
49. Bredt DS, Snyder SH. Nitric oxide, a novel neuronal messenger. Neuron 1992; 8: 3-11.
50. Jackson EB Jr, Mukhopadhyay S, Tulis DA. Pharmacologic modulators of soluble guanylate cyclase/cyclic guanosine monophosphate in the vascular system - from bench top to bedside. Curr Vasc Pharmacol 2007; 5:1-14.
51. Wiesel P, Patel AP, Carvajal IM, Wang ZY, Pellacani A, Maemura K, et al. Exacerbation of chronic renovascular hypertension and acute renal failure in heme oxygenase-1-deficient mice. Circ Res 2001; 88: 1088-94.
52. Theodorakis NG, Wang YN, Skill NJ, Metz MA, Cahill PA, Redmond EM, et al. The role of nitric oxide synthase isoforms in extrahepatic portal hypertension: Studies in gene-knockout mice. Gastroenterology 2003, 124: 1500-8.
53. Baumbach GL, Sigmund CD, Bottiglieri T, Lentz SR. Structure of cerebral arterioles in cystathionine beta-synthase-deficient mice. Circ Res 2002; 91: 931-7.
54. Griffith C, Garthwaite J. The shaping of nitric oxide signals by a cellular sink. J Physiol 2001; 536: 855-62.
55. Vladimirov Y, Borisenko G, Boriskina N, Kazarinov K, Osipov A. NO-hemoglobin may be a light-sensitive source of nitric oxide both in solution and in red blood. cells. J Photochem Photobiol B 2000; 59: 115-22.
56. Ding Y, McCoubrey WK Jr, Maines MD. Interaction of heme oxygenase-2 with nitric oxide donors. Is the oxygenase an intracellular 'sink' for NO? Eur J Biochem 1999; 264: 854-61.
57. Jensen DE, Belka GK, Du Bois GC. S-Nitrosoglutathione is a substrate for rat alcohol dehydrogenase class III isoenzyme. Biochem J 1998; 331: 659-68.
58. Thorup C, Jones CL, Gross SS, Moore LC, Goligorsky MS. Carbon monoxide induces vasodilation and nitric oxide release but suppresses endothelial NOS. Am J Physiol 1999; 277: F882-9.
59. Thom SR, Xu YA, Ischiropoulos H. Vascular endothelial cells generate peroxynitrite in response to carbon monoxide exposure. Chem Res Toxicol 1997; 10: 1023-31.
60. Gibson QH, Olson JS, McKinnie RE, Rohlfs RJ. A kinetic description of ligand binding to sperm whale myoglobin. J Biol Chem 1986; 261: 10228-39.
61. Turcanu V, Dhouib, Poindron P. Nitric oxide synthase inhibition by haem oxygenase decreases macrophage nitric-oxide-dependent cytotoxicity: A negative feedback mechanism for the regulation of nitric oxide production. Res Immunol 1998; 149: 741-4.
62. Willis D, Tomlinson A, Frederick R, Paul-Clark MJ, Willoughby DA. Modulation of heme oxygenase activity in rat brain and spleen by inhibitors and donors of nitric oxide. Biochem Biophys Res Commun 1995; 214: 1152-6.
63. Johnson FK, Durante W, Peyton KJ, Johnson RA. Heme oxygenase inhibitor restores arteriolar nitric oxide function in dahl rats. Hypertension 2003; 41: 149-55.
64. Ingi T, Cheng J, Ronnett GV. Carbon monoxide: An endogenous modulator of the nitric oxide-cyclic GMP signaling system. Neuron 1996; 16: 835-42.
65. Otterbein LE, Mantell LL, Choi AM. Carbon monoxide provides protection against hyperoxic lung injury. Am J Physiol 1999; 276: L688-94.
66. Taille C, Foresti R, Lanone S, Zedda C, Green C, Aubier M, et al. Protective role of heme oxygenases against endotoxin-induced diaphragmatic dysfunction in rats. Am J Respir Crit Care Med 2001; 163: 753-61.
67. Minamoto K, Harada H, Lama VN, Fedarau MA, Pinsky DJ. Reciprocal regulation of airway rejection by the inducible gas-forming enzymes heme oxygenase and nitric oxide synthase. J Exp Med 2005; 202: 283-94.
68. Sawle P, Foresti R, Mann BE, Johnson TR, Green CJ, Motterlini R. Carbon monoxide-releasing molecules (CO-RMs) attenuate the inflammatory response elicited by lipopolysaccharide in RAW264.7 murine macrophages. Br J Pharmacol 2005; 145: 800-10.
69. Srisook K, Han SS, Choi HS, Li MH, Ueda H, Kim C, et al. CO from enhanced HO activity or from CORM-2 inhibits both O2- and NO production and downregulates HO-1 expression in LPS-stimulated macrophages. Biochem Pharmacol 2006; 71: 307-18.
70. Foresti R, Motterlini R. The heme oxygenase pathway and its interaction with nitric oxide in the control of cellular homeostasis. Free Radic Res 1999; 31: 459-75.
71. Wang WW, Smith DL, Zucker SD. Bilirubin inhibits iNOS expression and NO production in response to endotoxin in rats. Hepatology 2004; 40: 424-33.
72. Colville-Nash PR, Qureshi SS, Willis D, Willoughby DA. Inhibition of inducible nitric oxide synthase by peroxisome proliferator-activated receptor agonists: Correlation with induction of heme oxygenase 1. J Immunol 1998; 161(2): 978-84.
73. Taille C, El-Benna J, Lanone S, Boczkowski J, Motterlini R. Mitochondrial respiratory chain and NAD(P)H oxidase are targets for the antiproliferative effect of carbon monoxide in human airway smooth muscle. J Biol Chem 2005; 280: 25350-60.
74. Hosoki R, Matsuki N, Kimura H. The possible role of hydrogen sulfide as an endogenous smooth muscle relaxant in synergy with nitric oxide. Biochem Biophys Res Commun 1997; 237: 527-31.
75. Li X, Do J, Jin H, Tang X, Bu D, Tang C. The regulatory effect of endogenous hydrogen sulfide on pulmonary vascular structure and gasotransmitters in rats with high pulmonary blood flow. Life Sci 2007; 81: 841-9.
76. Oh GS, Pae HO, Lee BS, Kim BN, Kim JM, Kim HR, et al. Hydrogen sulfide inhibits nitric oxide production and nuclear factor-kappaB via heme oxygenase-1 expression in RAW264.7 macrophages stimulated with lipopolysaccharide. Free Radic Biol Med 2006; 41: 106-19.
77. Lee BS, Heo J, Kim YM, Shim SM, Pae HO, Kim YM, et al. Carbon monoxide mediates heme oxygenase 1 induction via Nrf2 activation in hepatoma cells. Biochem Biophys Res Common 2006; 343: 965-72.
78. Kim KM, Pae HO, Zhung M, Park R, Kim YM, Chung HT. Carbon monoxide induces heme oxygenase-1 via activation of protein kinase R like endoplasmic reticulum kinase and inhibits endothelial cell apoptosis triggered by endoplasmic reticuluin stress. Circ Res 2007; 101: 1-6
79. Ishikawa K, Sugawara D, Goto J, Watanabe Y, Kawamura K Shiomi M, et al. Heme oxygenase-1 inhibits atherogenesis in Watanabe heritable hyperlipidemic rabbits. Ciiculation 2001; 104: 1831-6.
80. Juan SH, Lee TS, Tseng KW, Liou JY, Shyue SK, Wu KK, et al. Adenovirus-mediated heme oxygenase-1 gene transfer inhibits the development of atherosclerosis in apolipoprotein E-deficient mice. Circulation 2001; 104: 1519-25.
81. Deng YM, Wu BJ, Witting PK, Stocker R. Probucol protects against smooth muscle cell proliferation by upregulating heme oxygenase-1. Circulation 2004; 110: 1855-60.
82. Wu BJ, Kathir K, Witting PK, Beck K, Choy K, Li C, et al. Antioxidants protect from atherosclerosis by a heme oxygenase-1 pathway that is independent of free radical scavenging. J Exp Med 2006; 203: 1117-27.
83. Liu XM, Azam MA, Peyton KJ, Ensenat D, Keswani AN, Wang H, et al. Butylated hydroxyanisole stimulates heme oxygenase-1 gene expression and inhibits neointima formation in rat arteries. Cardiovasc Res 2007; 74: 169-79.
84. Motterlini R, Foresti R, Bassi R, Green CJ. Curcumin, an antioxidant and anti-inflammatory agent, induces heme oxygenase-1 and protects endothelial cells against oxidative stress. Free Radic Biol Med 2000; 28: 1363-12.
85. Pae HO, Tering GS, Jeong SO, Kim HS, Kim SA, Kim YC, et al. Roles of heme oxygenase-1 in curcumin-induced growth inhibition in Tat smooth muscle cells. Exp Mol Med 2007; 39: 267-77.
86. Balogun E, Hoque M, Gong P, Killeen E, Green CJ, Foresti R, et al. Curcumin activates the haem oxygenase-1 gene via regulation of Nrf2 and the antioxidant-responsive element. Biochem J 2003; 371: 887-95.
87. Chauveau C, Bouchet D, Roussel JC, Mathieu P, Braudeau C, Renaudin K, et al. Gene transfer of heme oxygenase-1 and carbon monoxide delivery inhibit chronic rejection. Am J Transplant 2002; 2: 581-92
88. Foresti R, Hammad J, Clark JE, Johnson TR, Mann BE, Friebe A, et al. Vasoactive properties of CORM-3, a novel water-soluble carbon monoxide-releasing molecule. Br J Pharmacol 2004; 142: 453-60.
89. Fujita T, Toda K, Kanmova A, Yan SF, Naka Y, Yet SF, et al. Paradoxical rescue from ischemic lung injury by inhaled carbon monoxide driven by derepression of fibrinolysis. Nat Med 2001; 7: 598-604.
90. Ramlawi B, Scott JR, Feng J, Mieno S, Raman KG, Gallo D, et al. Inhaled carbon monoxide prevents graft-induced. intimal hyperplasia in swine, J Surg Res 2007; 138: 121-7.
91. Boos CJ, Lip GY. Is hypertension an inflammatory process? Curr Pharm Des 2006; 12(13): 1623-35.
92. Fukuto JM, Collins MD. Interactive endogenous small molecule (gaseous) signaling: Implications for teratogenesis. Curr Pharm Des 2007; 13(29): 2952-78.
93. Yatomi Y. Sphingosine 1-phosphate in vascular biology: Possible therapeutic strategies to control vascular diseases. Curr Pharm Des 2006; 12(5): 575-87.